• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侧向流动免疫测定试验在 SARS-CoV-2 血清流行率调查中的表现:一项针对医护人员的验证研究。

A lateral flow immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers.

机构信息

CHU de Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), Rennes, France.

CHU de Rennes, Rennes, France.

出版信息

Emerg Microbes Infect. 2020 Dec;9(1):2547-2549. doi: 10.1080/22221751.2020.1852893.

DOI:10.1080/22221751.2020.1852893
PMID:33206004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7717860/
Abstract

The objective of this study was to evaluate the validity and reliability of NG-Test® when used as a finger-prick test on healthcare workers and to compare it to the ELISA Wantai Immunoassay. Fifty-one healthcare workers who were RT-PCR SARS-CoV-2 positive and 59 who were RT-PCR SARS-CoV-2 negative accepted to participate in this study. They were subjected to an NG-Test® finger-prick test and collection of a blood sample on the same day. A second NG-Test® on another finger was performed for the first 30 cases and controls and read blinded to the first. Sera obtained from blood samples were used to perform the Wantai SARS-CoV-2 ELISA. The interobserver agreement for the NG-Test® test was perfect (kappa coefficient = 100% [98%-100%]). The sensitivity of NG-Test® was estimated to be 85% [71.9%-92.3%] and the specificity 98.3% [95.0%-100.0%]) for both IgG and IgM. The percentage of agreement between the Wantai immunoassay and NG-Test® was 92.73% for IgG (Kappa = 0.85 [0.75-0.95]) and 65.45% (Kappa = 0.42 [0.26-0.58]) for IgM. Our study highlights the need to validate rapid immunoassay tests under real-life conditions. If NG-Test® is used in seroprevalence surveys, we recommend that its diagnostic performance be taken into consideration to obtain a reliable estimation.

摘要

本研究旨在评估 NG-Test®作为指尖采血检测在医护人员中的有效性和可靠性,并与 ELISA 万泰免疫测定法进行比较。51 名 RT-PCR SARS-CoV-2 阳性和 59 名 RT-PCR SARS-CoV-2 阴性的医护人员同意参与本研究。他们当天接受了 NG-Test®指尖采血检测,并采集了血液样本。前 30 例和对照组进行了第二次 NG-Test®,对第二个手指进行了检测,检测结果对第一个结果进行了盲法读取。从血液样本中获得的血清用于进行万泰 SARS-CoV-2 ELISA。NG-Test®检测的观察者间一致性为完美(kappa 系数=100%[98%-100%])。NG-Test®的敏感性估计为 85%[71.9%-92.3%],特异性为 98.3%[95.0%-100.0%]),IgG 和 IgM 均如此。万泰免疫测定法和 NG-Test®的 IgG 之间的一致性百分比为 92.73%(kappa =0.85[0.75-0.95]),IgM 为 65.45%(kappa =0.42[0.26-0.58])。本研究强调了在现实条件下验证快速免疫检测的必要性。如果在血清流行率调查中使用 NG-Test®,我们建议考虑其诊断性能以获得可靠的估计。

相似文献

1
A lateral flow immunoassay test performance in SARS-CoV-2 seroprevalence surveys: a validation study among healthcare workers.侧向流动免疫测定试验在 SARS-CoV-2 血清流行率调查中的表现:一项针对医护人员的验证研究。
Emerg Microbes Infect. 2020 Dec;9(1):2547-2549. doi: 10.1080/22221751.2020.1852893.
2
Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.五种用于 SARS-CoV-2 抗体诊断的免疫分析方法在真实临床常规检测环境中的临床诊断性能评估。
Pan Afr Med J. 2021 May 3;39:3. doi: 10.11604/pamj.2021.39.3.26471. eCollection 2021.
3
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).评估三种免疫测定法(Euroimmun 和 Abbott 的两种自动化免疫测定法以及 NG Biotech 的一种快速侧向流动免疫测定法)用于诊断 COVID-19 的 SARS-CoV-2 血清学检测。
J Clin Virol. 2020 Aug;129:104511. doi: 10.1016/j.jcv.2020.104511. Epub 2020 Jun 15.
4
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).两种 SARS-CoV-2 IgG/IgM 快速检测试剂(Covid-Presto 和 NG-Test)和一种 IgG 自动化免疫分析(雅培)的性能评估。
J Clin Virol. 2020 Nov;132:104618. doi: 10.1016/j.jcv.2020.104618. Epub 2020 Sep 3.
5
SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.COVID-19 大流行第一波期间考纳斯医院医护人员中 SARS-CoV-2 的血清流行率。
Medicina (Kaunas). 2021 Feb 6;57(2):148. doi: 10.3390/medicina57020148.
6
Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.评价两种 SARS-CoV-2 快速 IgM-IgG 联合抗体检测试剂盒在指尖毛细血管全血样本中的性能。
PLoS One. 2020 Sep 17;15(9):e0237694. doi: 10.1371/journal.pone.0237694. eCollection 2020.
7
Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil.巴西 100 名医护人员的研究数据:三种即时侧向流动免疫分析法检测抗 SARS-CoV-2 抗体的比较分析。
Braz J Microbiol. 2021 Sep;52(3):1161-1165. doi: 10.1007/s42770-021-00498-z. Epub 2021 Apr 19.
8
Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers.新冠病毒血清学检测的验证和无症状医护人员的大规模筛查。
Clin Biochem. 2021 Apr;90:23-27. doi: 10.1016/j.clinbiochem.2021.01.004. Epub 2021 Jan 17.
9
Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.用 SARS-CoV-2 IgG-IgM 抗体快速检测试剂盒检测来自欧洲和非洲的大流行前血标本时,出现了出乎意料的高频率非特异性反应,这表明 IgM 是“阿喀琉斯之踵”。
J Med Virol. 2021 Apr;93(4):2196-2203. doi: 10.1002/jmv.26628. Epub 2020 Nov 22.
10
SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study.用于国家新冠病毒血清流行率调查(React 2)的可能用途的 SARS-CoV-2 侧向流动检测:诊断准确性研究。
BMJ. 2021 Mar 2;372:n423. doi: 10.1136/bmj.n423.

引用本文的文献

1
Comparison of NADAL COVID IgG/IgM rapid test and DiaSorin Liaison SARS-CoV-2 S1/S2 IgG assay across different blood sources and substrates.NADAL COVID IgG/IgM快速检测与DiaSorin Liaison SARS-CoV-2 S1/S2 IgG检测在不同血液来源和基质中的比较。
Microbiol Spectr. 2025 Jul;13(7):e0335024. doi: 10.1128/spectrum.03350-24. Epub 2025 Jun 2.
2
High seroprevalence of antibodies against SARS-CoV-2 among healthcare workers 8 months after the first wave in Aden, Yemen.也门亚丁第一波疫情过去8个月后,医护人员中抗新冠病毒抗体的血清阳性率很高。
PLOS Glob Public Health. 2022 Nov 9;2(11):e0000767. doi: 10.1371/journal.pgph.0000767. eCollection 2022.
3
SARS-CoV-2 seroprevalence and antibodies persistence among health care workers after the first COVID-19 wave in nine hospitals in Western France.法国西部 9 家医院在首次 COVID-19 浪潮后医护人员中 SARS-CoV-2 血清流行率和抗体持久性。
Infect Dis Now. 2022 Nov;52(8):447-452. doi: 10.1016/j.idnow.2022.09.004. Epub 2022 Sep 13.
4
Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays.用于检测非重症病例门诊随访和接种后不同时间抗 SARS-CoV-2 IgG 的侧向流动免疫分析的技术性能:与酶和化学发光免疫分析的比较。
Rev Inst Med Trop Sao Paulo. 2022 Jul 13;64:e49. doi: 10.1590/S1678-9946202264049. eCollection 2022.
5
SARS-CoV-2 Molecular Diagnostics in China.新型冠状病毒分子诊断在中国。
Clin Lab Med. 2022 Jun;42(2):193-201. doi: 10.1016/j.cll.2022.03.003. Epub 2022 Mar 4.
6
COVID-19 Antibody Detecting Rapid Diagnostic Tests Show High Cross-Reactivity When Challenged with Pre-Pandemic Malaria, Schistosomiasis and Dengue Samples.新冠病毒抗体检测快速诊断测试在使用大流行前的疟疾、血吸虫病和登革热样本进行检测时显示出高交叉反应性。
Diagnostics (Basel). 2021 Jun 25;11(7):1163. doi: 10.3390/diagnostics11071163.

本文引用的文献

1
Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.使用床边即时检验,快速测定 SARS-CoV-2 抗体。
Emerg Microbes Infect. 2020 Dec;9(1):2212-2221. doi: 10.1080/22221751.2020.1826892.
2
Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting.四种用于 SARS-CoV-2 抗体的免疫分析方法的临床性能,包括在现实常规护理环境中对 COVID-19 进行诊断的前瞻性分析。
J Clin Virol. 2020 Nov;132:104633. doi: 10.1016/j.jcv.2020.104633. Epub 2020 Sep 8.
3
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).两种 SARS-CoV-2 IgG/IgM 快速检测试剂(Covid-Presto 和 NG-Test)和一种 IgG 自动化免疫分析(雅培)的性能评估。
J Clin Virol. 2020 Nov;132:104618. doi: 10.1016/j.jcv.2020.104618. Epub 2020 Sep 3.
4
Humoral Immune Response to SARS-CoV-2.体液免疫对 SARS-CoV-2 的应答。
Am J Clin Pathol. 2020 Oct 13;154(5):610-619. doi: 10.1093/ajcp/aqaa140.
5
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.评估中国上海轻症 COVID-19 康复患者临床特征与中和抗体水平的相关性。
JAMA Intern Med. 2020 Oct 1;180(10):1356-1362. doi: 10.1001/jamainternmed.2020.4616.
6
Neutralizing Antibodies Against SARS-CoV-2-Important Questions, Unclear Answers.针对严重急性呼吸综合征冠状病毒2的中和抗体——重要问题,答案不明
JAMA Intern Med. 2020 Oct 1;180(10):1362. doi: 10.1001/jamainternmed.2020.4624.
7
Adjusting Coronavirus Prevalence Estimates for Laboratory Test Kit Error.调整冠状病毒流行率估计值以消除实验室检测试剂盒误差。
Am J Epidemiol. 2021 Jan 4;190(1):109-115. doi: 10.1093/aje/kwaa174.
8
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).评估三种免疫测定法(Euroimmun 和 Abbott 的两种自动化免疫测定法以及 NG Biotech 的一种快速侧向流动免疫测定法)用于诊断 COVID-19 的 SARS-CoV-2 血清学检测。
J Clin Virol. 2020 Aug;129:104511. doi: 10.1016/j.jcv.2020.104511. Epub 2020 Jun 15.
9
Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital.比较疑似 2019 年冠状病毒病患者在就诊医院时,快速血清学检测与 ELISA 检测以及分子诊断学检测的诊断准确性。
Clin Microbiol Infect. 2020 Aug;26(8):1094.e7-1094.e10. doi: 10.1016/j.cmi.2020.05.028. Epub 2020 Jun 2.
10
Interpreting Diagnostic Tests for SARS-CoV-2.解读新型冠状病毒2019(SARS-CoV-2)诊断检测结果
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.